Immune response induced by the recombinant novel coronavirus vaccine (Adenovirus type 5 vector) (Ad5-nCoV) in persons living with HIV (PLWH)

Immune response induced by the recombinant novel coronavirus vaccine (Adenovirus type 5 vector) (Ad5-nCoV) in persons living with HIV (PLWH)

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Pedro Cahn, Luis Barreto, Maria Ines Figueroa, Valeria Fink, Maria Jose Rolon, Gustavo Lopardo, Isabel Cassetti, Mariela Ceschel, Patricia Patterson, Luciana Gambardella, Gissella Mernies, Agustin Nava, Jinbo Gou, Ruijie Wang, Tao Zhu, Scott A. Halperin
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12157306/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immune response induced by the recombinant novel coronavirus vaccine (Adenovirus type 5 vector) (Ad5-nCoV) in persons living with HIV (PLWH).
by: Pedro Cahn, et al.
Published: (2025-01-01)

Safety and immunogenicity of Ad5-nCoV administered intradermally by needle-free injector in rats
by: Li Chen, et al.
Published: (2025-02-01)

Characterization of the gut microbiota in different immunological responses among PLWH
by: Yanyan Guo, et al.
Published: (2025-04-01)

CAR modulates E-cadherin dynamics in the presence of adenovirus type 5.
by: Fawziyah Hussain, et al.
Published: (2011-01-01)

The Role of Autophagy in HIV Infection and Immunological Recovery of ART-Treated PLWH
by: Mayara Sabino Leite de Oliveira Duarte, et al.
Published: (2025-06-01)

Antibody dynamics for heterologous boosters with aerosolized Ad5-nCoV following inactivated COVID-19 vaccines
by: Canjie Chen, et al.
Published: (2024-12-01)

ADENOVIRUS TYPE 5 REACTIVATION IN T- LYMPHOBLAST HUMAN CELL AFTER ETOPOSIDE TREATMENT
by: Zeenah Weheed Atwan
Published: (2020-04-01)

Survival analysis of PLWH on antiretroviral therapy in Henan Province from 2004 to 2024
by: Meng Deng, et al.
Published: (2025-07-01)

Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial
by: Lairun Jin, et al.
Published: (2023-12-01)

Comparing the protection of heterologous booster of inhaled Ad5-nCoV vaccine and hybrid immunity against Omicron BA.5 infection: a cohort study of hospital staff in China
by: Kai Wang, et al.
Published: (2024-12-01)

Change in WHO cardiovascular risk prediction over three years in PLWH on efavirenz-based ART
by: Melani Ratih Mahanani, et al.
Published: (2025-07-01)

Patterns and Correlates of Tobacco Use Among PLWH in Viet Nam: A Cross-Sectional Analysis
by: Reet Kapur, et al.
Published: (2025-06-01)

Effects of Adenovirus Type 5 E1A Isoforms on Viral Replication in Arrested Human Cells.
by: Sandi Radko, et al.
Published: (2015-01-01)

Adenovirus Nanoparticles Displaying RBD Induce a Protective Immune Response Against BA.5 in Mice
by: Mo C, et al.
Published: (2025-08-01)

Prognostic Value of Procalcitonin in Febrile People Living with Human Immunodeficiency Virus (PLWH) Admitted to the Emergency Department
by: Luigi Celani, et al.
Published: (2025-01-01)

Analysis of PLWH switching to medical insurance ART: a cross-sectional study in six Chinese provinces
by: Jingkun Hu, et al.
Published: (2024-12-01)

Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trial
by: Jia-Wei Xu, et al.
Published: (2024-12-01)

NYPD Red 5 /
by: Patterson, James
Published: (2018)

Association Between HLA Class II Gene Polymorphisms and Cytokine Levels in PLWH with HIV-Related Dermatoses in Latvia
by: Alena Soha, et al.
Published: (2025-06-01)

Estimating risk of acquiring SARS-COV2 infection in treatment-experienced PLWH: A case-control study
by: Pierluigi Francesco Salvo, et al.
Published: (2025-06-01)

Impact of population movement on the spread of 2019-nCoV in China
by: Chi Zhang, et al.
Published: (2020-01-01)

HIV-1 did not contribute to the 2019-nCoV genome
by: Chuan Xiao, et al.
Published: (2020-01-01)

Cancer Awareness Among People Living with HIV (PLWH): Insights from an Italian Survey of Oncologists and Infectious Disease Specialists
by: Dalu D, et al.
Published: (2025-07-01)

Social support and the effects of the COVID-19 pandemic among a cohort of people living with HIV (PLWH) in Western Kenya.
by: Adel Mburia-Mwalili, et al.
Published: (2023-01-01)

How Antiretroviral Drug Concentrations Could Be Affected by Oxidative Stress, Physical Capacities and Genetics: A Focus on Dolutegravir Treated Male PLWH
by: Jessica Cusato, et al.
Published: (2025-01-01)

Ad5-nCoV boosted vaccine and reinfection-induced memory T/B cell responses and humoral immunity to SARS-CoV-2: based on two prospective cohorts
by: Aidibai Simayi, et al.
Published: (2024-12-01)

Retrospective Analysis of 2019-nCov-Infected Cases in Dongyang, Southeastern China
by: G. G. Li, et al.
Published: (2020-01-01)

Immunomodulatory responses of toll like receptors against 2019nCoV
by: Amany Sayed Maghraby
Published: (2021-06-01)

Cellular transcriptomics of arrested normal lung fibroblasts IMR-90 infected with Human Adenovirus 5 E1A mutants.
by: Rafe Helwer, et al.
Published: (2025-01-01)

Cellular transcriptomics of arrested normal lung fibroblasts IMR-90 infected with Human Adenovirus 5 E1A mutants
by: Rafe Helwer, et al.
Published: (2025-01-01)

Correction: Social support and the effects of the COVID-19 pandemic among a cohort of People Living with HIV (PLWH) in Western Kenya
Published: (2025-01-01)

Accelerated Titering of Adenoviruses
by: Burkhard Bewig, et al.
Published: (2000-05-01)

The seroprevalence of adenoviruses since 20001
by: Lingling Hong, et al.
Published: (2025-12-01)

Oral priming with replicating adenovirus serotype 4 followed by subunit H5N1 vaccine boost promotes antibody affinity maturation and expands H5N1 cross-clade neutralization.
by: Surender Khurana, et al.
Published: (2015-01-01)

Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell cultures.
by: Di Yu, et al.
Published: (2013-01-01)

Overcoming immune resistance in advanced esophageal squamous cell carcinoma with recombinant human adenovirus type 5 by impacting the immune microenvironment: a case report
by: Zhongting Wang, et al.
Published: (2025-06-01)

Cutaneous Leukocytoclastic Vasculitis after ChAdOx1 nCoV-19 Vaccine
by: Mansoor C. Abdulla
Published: (2022-10-01)

Simulation of epidemic trends of 2019-nCoV epidemic trend under effective control measures
by: Ru-Hai BAI, et al.
Published: (2020-04-01)

Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes
by: Wei Zhang, et al.
Published: (2020-01-01)

How to prevent the infection of the novel coronavirus (2019-nCoV) in pediatric blood purification center
by: WANG Mo, et al.
Published: (2020-01-01)